Just over half of doctors declare fees from drug companiesBMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j1574 (Published 28 March 2017) Cite this as: BMJ 2017;356:j1574
- Ingrid Torjesen
Only around half of doctors and other healthcare professionals are putting their names to payments and benefits they receive from drug companies in the register managed by the industry’s trade association—far fewer than previously claimed.
A new analysis of data submitted to the Association of the British Pharmaceutical Industry’s Disclosure UK database (www.disclosureuk.org.uk) has found that just 55% of doctors and other healthcare professionals are allowing their names to appear alongside the fees and expenses they receive from drug companies, not the 70% that was claimed in June 2016 when the scheme launched.1
The database lists details of the fees and benefits in kind paid by the industry to doctors, pharmacists, nurses, and healthcare organisations. Only those that consent to be identified are named, and the remainder of the information is published in aggregate form.
Mike Thompson, chief executive officer …